cbdMD, Inc.
YCBD · AMEX
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $4,607 | $4,749 | $5,113 | $4,556 |
| % Growth | -3% | -7.1% | 12.2% | – |
| Cost of Goods Sold | $1,776 | $1,790 | $1,713 | $2,103 |
| Gross Profit | $2,831 | $2,959 | $3,401 | $2,454 |
| % Margin | 61.5% | 62.3% | 66.5% | 53.9% |
| R&D Expenses | $10 | $0 | $3 | $22 |
| G&A Expenses | $1,741 | $1,761 | $1,730 | $1,858 |
| SG&A Expenses | $2,992 | $2,885 | $2,731 | $2,763 |
| Sales & Mktg Exp. | $1,251 | $1,124 | $1,001 | $905 |
| Other Operating Expenses | $734 | $560 | $753 | -$14 |
| Operating Expenses | $3,736 | $3,445 | $3,487 | $2,770 |
| Operating Income | -$905 | -$486 | -$86 | -$317 |
| % Margin | -19.6% | -10.2% | -1.7% | -6.9% |
| Other Income/Exp. Net | $9 | $5 | $101 | $164 |
| Pre-Tax Income | -$895 | -$481 | $15 | -$153 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$895 | -$1,481 | $15 | -$153 |
| % Margin | -19.4% | -31.2% | 0.3% | -3.4% |
| EPS | -0.21 | -19.03 | -0.22 | 1.52 |
| % Growth | 98.9% | -8,550% | -114.5% | – |
| EPS Diluted | -0.21 | -1.9 | -0.22 | 1.52 |
| Weighted Avg Shares Out | 5,783 | 78 | 4,552 | 4,313 |
| Weighted Avg Shares Out Dil | 5,783 | 7,784 | 4,552 | 4,313 |
| Supplemental Information | – | – | – | – |
| Interest Income | $9 | $8 | $11 | $2 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $449 | $576 | $339 | $76 |
| EBITDA | -$456 | $95 | $253 | $276 |
| % Margin | -9.9% | 2% | 4.9% | 6.1% |